My Quote Request
No products added yet
6505-01-211-7117
20 Products
MC SOLUTION
METHYLCELLULOSE ORAL SOLUTION,USP
NSN, MFG P/N
6505012117117
NSN
6505-01-211-7117
MC SOLUTION
METHYLCELLULOSE ORAL SOLUTION,USP
NSN, MFG P/N
6505012117117
NSN
6505-01-211-7117
MFG
E-Z-EM INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 PERCENTAGE, W/V HYDROXYPROPYL METHYLCELLULOSE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 1900.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE, PLASTIC
SPECIAL FEATURES: FOR DOUBLE CONTRAST RADIOLOGIC EXAMINATIONS OF THE COLON
TOTAL PRIMARY CONTAINER QUANTITY: 4
Related Searches:
NDC00009-0114-04
TOLAZAMIDE TABLETS,USP
NSN, MFG P/N
6505012118356
NSN
6505-01-211-8356
NDC00009-0114-04
TOLAZAMIDE TABLETS,USP
NSN, MFG P/N
6505012118356
NSN
6505-01-211-8356
MFG
PHARMACIA & UPJOHN COMPANY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 250.000 MILLIGRAMS TOLAZAMIDE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 200.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: COATING FEATURE:COMPRESSION
Related Searches:
TOLINASE
TOLAZAMIDE TABLETS,USP
NSN, MFG P/N
6505012118356
NSN
6505-01-211-8356
MFG
PHARMACIA & UPJOHN COMPANY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 250.000 MILLIGRAMS TOLAZAMIDE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 200.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: COATING FEATURE:COMPRESSION
Related Searches:
NDC00007-4471-20
TRANYLCYPROMINE SULFATE TABLETS,USP
NSN, MFG P/N
6505012119008
NSN
6505-01-211-9008
NDC00007-4471-20
TRANYLCYPROMINE SULFATE TABLETS,USP
NSN, MFG P/N
6505012119008
NSN
6505-01-211-9008
MFG
GLAXOSMITHKLINE HOLDINGS AMERICAS INC. DIV SMITHKLINE BEECHAM CORPORATION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS TRANYLCYPROMINE SULFATE ACTIVE INGREDIENT
COATING FEATURE: SUGAR
III PART NAME ASSIGNED BY CONTROLLING AGENCY: TRANYLCYPROMINE SULFATE TABLETS USP 10 MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
PARNATE
TRANYLCYPROMINE SULFATE TABLETS,USP
NSN, MFG P/N
6505012119008
NSN
6505-01-211-9008
PARNATE
TRANYLCYPROMINE SULFATE TABLETS,USP
NSN, MFG P/N
6505012119008
NSN
6505-01-211-9008
MFG
GLAXOSMITHKLINE HOLDINGS AMERICAS INC. DIV SMITHKLINE BEECHAM CORPORATION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS TRANYLCYPROMINE SULFATE ACTIVE INGREDIENT
COATING FEATURE: SUGAR
III PART NAME ASSIGNED BY CONTROLLING AGENCY: TRANYLCYPROMINE SULFATE TABLETS USP 10 MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
162
REHYDRATION SALTS ORAL SOLUTION
NSN, MFG P/N
6505012119614
NSN
6505-01-211-9614
MFG
ABBOTT LABORATORIES INC ROSS PRODUCTS DIV
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: REHYDRATION ELECTROLYTE ORAL SOLUTION 240ML OR 8OZ BT 24S PG
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PRIMARY CONTAINER CONTENT QUANTITY: 240.000 MILLILITERS OR 8.000 FLUID OUNCES
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: EACH BOTTLE CONTAINS 17.7 MEQ SODIUM. 4.7 MEQ POTASSIUM,15.4 MEQ CHLORIDE,7.1 MEQ CITRATE,5.9 GM DEXTROSE; 24 CALORIES PER BOTTLE; READY TO USE
TOTAL PRIMARY CONTAINER QUANTITY: 24
Related Searches:
NDC00074-0162-01
REHYDRATION SALTS ORAL SOLUTION
NSN, MFG P/N
6505012119614
NSN
6505-01-211-9614
NDC00074-0162-01
REHYDRATION SALTS ORAL SOLUTION
NSN, MFG P/N
6505012119614
NSN
6505-01-211-9614
MFG
ABBOTT LABORATORIES INC ROSS PRODUCTS DIV
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: REHYDRATION ELECTROLYTE ORAL SOLUTION 240ML OR 8OZ BT 24S PG
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PRIMARY CONTAINER CONTENT QUANTITY: 240.000 MILLILITERS OR 8.000 FLUID OUNCES
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: EACH BOTTLE CONTAINS 17.7 MEQ SODIUM. 4.7 MEQ POTASSIUM,15.4 MEQ CHLORIDE,7.1 MEQ CITRATE,5.9 GM DEXTROSE; 24 CALORIES PER BOTTLE; READY TO USE
TOTAL PRIMARY CONTAINER QUANTITY: 24
Related Searches:
REHYDRALYTE
REHYDRATION SALTS ORAL SOLUTION
NSN, MFG P/N
6505012119614
NSN
6505-01-211-9614
REHYDRALYTE
REHYDRATION SALTS ORAL SOLUTION
NSN, MFG P/N
6505012119614
NSN
6505-01-211-9614
MFG
ABBOTT LABORATORIES INC ROSS PRODUCTS DIV
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: REHYDRATION ELECTROLYTE ORAL SOLUTION 240ML OR 8OZ BT 24S PG
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PRIMARY CONTAINER CONTENT QUANTITY: 240.000 MILLILITERS OR 8.000 FLUID OUNCES
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: EACH BOTTLE CONTAINS 17.7 MEQ SODIUM. 4.7 MEQ POTASSIUM,15.4 MEQ CHLORIDE,7.1 MEQ CITRATE,5.9 GM DEXTROSE; 24 CALORIES PER BOTTLE; READY TO USE
TOTAL PRIMARY CONTAINER QUANTITY: 24
Related Searches:
REHYDRALYTE SOLUTION
REHYDRATION SALTS ORAL SOLUTION
NSN, MFG P/N
6505012119614
NSN
6505-01-211-9614
REHYDRALYTE SOLUTION
REHYDRATION SALTS ORAL SOLUTION
NSN, MFG P/N
6505012119614
NSN
6505-01-211-9614
MFG
ABBOTT LABORATORIES INC ROSS PRODUCTS DIV
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: REHYDRATION ELECTROLYTE ORAL SOLUTION 240ML OR 8OZ BT 24S PG
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PRIMARY CONTAINER CONTENT QUANTITY: 240.000 MILLILITERS OR 8.000 FLUID OUNCES
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: EACH BOTTLE CONTAINS 17.7 MEQ SODIUM. 4.7 MEQ POTASSIUM,15.4 MEQ CHLORIDE,7.1 MEQ CITRATE,5.9 GM DEXTROSE; 24 CALORIES PER BOTTLE; READY TO USE
TOTAL PRIMARY CONTAINER QUANTITY: 24
Related Searches:
6-0292
PHENYTOIN SODIUM INJECTION,USP
NSN, MFG P/N
6505012119769
NSN
6505-01-211-9769
6-0292
PHENYTOIN SODIUM INJECTION,USP
NSN, MFG P/N
6505012119769
NSN
6505-01-211-9769
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS PHENYTOIN SODIUM PER MILLILITER
ADMINISTRATION: INTRAMUSCULAR OR INTRAVENOUS
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 MILLILITERS
PRIMARY CONTAINER TYPE: SYRINGE WITH NEEDLE
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
DILANTIN
PHENYTOIN SODIUM INJECTION,USP
NSN, MFG P/N
6505012119769
NSN
6505-01-211-9769
DILANTIN
PHENYTOIN SODIUM INJECTION,USP
NSN, MFG P/N
6505012119769
NSN
6505-01-211-9769
MFG
PARKE-DAVIS DIV OF WARNER-LAMBERT CO
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS PHENYTOIN SODIUM PER MILLILITER
ADMINISTRATION: INTRAMUSCULAR OR INTRAVENOUS
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 MILLILITERS
PRIMARY CONTAINER TYPE: SYRINGE WITH NEEDLE
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
DILANTIN STERI DOSE
PHENYTOIN SODIUM INJECTION,USP
NSN, MFG P/N
6505012119769
NSN
6505-01-211-9769
DILANTIN STERI DOSE
PHENYTOIN SODIUM INJECTION,USP
NSN, MFG P/N
6505012119769
NSN
6505-01-211-9769
MFG
PARKE-DAVIS DIV OF WARNER-LAMBERT CO
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS PHENYTOIN SODIUM PER MILLILITER
ADMINISTRATION: INTRAMUSCULAR OR INTRAVENOUS
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 MILLILITERS
PRIMARY CONTAINER TYPE: SYRINGE WITH NEEDLE
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
NDC00071-4488-47
PHENYTOIN SODIUM INJECTION,USP
NSN, MFG P/N
6505012119769
NSN
6505-01-211-9769
NDC00071-4488-47
PHENYTOIN SODIUM INJECTION,USP
NSN, MFG P/N
6505012119769
NSN
6505-01-211-9769
MFG
PARKE-DAVIS DIV OF WARNER-LAMBERT CO
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS PHENYTOIN SODIUM PER MILLILITER
ADMINISTRATION: INTRAMUSCULAR OR INTRAVENOUS
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 MILLILITERS
PRIMARY CONTAINER TYPE: SYRINGE WITH NEEDLE
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
7504
FUROSEMIDE INJECTION,USP
NSN, MFG P/N
6505012121286
NSN
6505-01-212-1286
MFG
LYPHOMED INC DIV OF FUJISAWA USA INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS FUROSEMIDE PER MILLILITER
ADMINISTRATION: INTRAMUSCULAR OR INTRAVENOUS
PRIMARY CONTAINER CONTENT QUANTITY: 4.000 MILLILITERS
PRIMARY CONTAINER QUANTITY PER SECONDARY CONTAINER: 25 VIAL
PRIMARY CONTAINER TYPE: VIAL
SECONDARY CONTAINER TYPE: BOX
SPECIAL FEATURES: 4 ML FILL IN A 5 ML VIAL
TOTAL PRIMARY CONTAINER QUANTITY: 100
TOTAL SECONDARY CONTAINER QUANTITY: 4
Related Searches:
NDC00469-7500-70
FUROSEMIDE INJECTION,USP
NSN, MFG P/N
6505012121286
NSN
6505-01-212-1286
NDC00469-7500-70
FUROSEMIDE INJECTION,USP
NSN, MFG P/N
6505012121286
NSN
6505-01-212-1286
MFG
LYPHOMED INC DIV OF FUJISAWA USA INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS FUROSEMIDE PER MILLILITER
ADMINISTRATION: INTRAMUSCULAR OR INTRAVENOUS
PRIMARY CONTAINER CONTENT QUANTITY: 4.000 MILLILITERS
PRIMARY CONTAINER QUANTITY PER SECONDARY CONTAINER: 25 VIAL
PRIMARY CONTAINER TYPE: VIAL
SECONDARY CONTAINER TYPE: BOX
SPECIAL FEATURES: 4 ML FILL IN A 5 ML VIAL
TOTAL PRIMARY CONTAINER QUANTITY: 100
TOTAL SECONDARY CONTAINER QUANTITY: 4
Related Searches:
2923
NITROGLYCERIN TRANSDERMAL SYSTEM
NSN, MFG P/N
6505012122991
NSN
6505-01-212-2991
2923
NITROGLYCERIN TRANSDERMAL SYSTEM
NSN, MFG P/N
6505012122991
NSN
6505-01-212-2991
MFG
CIBA-GEIGY CORP SUMMIT PHARMACEUTICALS DIV
Description
FEATURES PROVIDED: BANDAGE, ADHESIVE, NONSENSITIZED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: NITROGLYCERIN TRANSDERMAL SYSTEM 25MG 100 SYSTEMS PG
OVERALL STRENGTH IN SYSTEM: 25 MG NITROGLYCERIN ACTIVE INGREDIENT
SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,SUMMIT PHARMACEUTICALS,DIVISION OF CIBA-GEIGY CORPORATION
SYSTEM SIZE: 10 SQUARE CENTIMETER
USUAL DOSE: 0.2 MG RELEASED PER HOUR
Related Searches:
NDC00083-2105-30
NITROGLYCERIN TRANSDERMAL SYSTEM
NSN, MFG P/N
6505012122991
NSN
6505-01-212-2991
NDC00083-2105-30
NITROGLYCERIN TRANSDERMAL SYSTEM
NSN, MFG P/N
6505012122991
NSN
6505-01-212-2991
MFG
CIBA-GEIGY CORP CIBA PHARMACEUTICALS DIV
Description
FEATURES PROVIDED: BANDAGE, ADHESIVE, NONSENSITIZED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: NITROGLYCERIN TRANSDERMAL SYSTEM 25MG 100 SYSTEMS PG
OVERALL STRENGTH IN SYSTEM: 25 MG NITROGLYCERIN ACTIVE INGREDIENT
SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,SUMMIT PHARMACEUTICALS,DIVISION OF CIBA-GEIGY CORPORATION
SYSTEM SIZE: 10 SQUARE CENTIMETER
USUAL DOSE: 0.2 MG RELEASED PER HOUR
Related Searches:
NDC57267-0905-30
NITROGLYCERIN TRANSDERMAL SYSTEM
NSN, MFG P/N
6505012122991
NSN
6505-01-212-2991
NDC57267-0905-30
NITROGLYCERIN TRANSDERMAL SYSTEM
NSN, MFG P/N
6505012122991
NSN
6505-01-212-2991
MFG
CIBA-GEIGY CORP SUMMIT PHARMACEUTICALS DIV
Description
FEATURES PROVIDED: BANDAGE, ADHESIVE, NONSENSITIZED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: NITROGLYCERIN TRANSDERMAL SYSTEM 25MG 100 SYSTEMS PG
OVERALL STRENGTH IN SYSTEM: 25 MG NITROGLYCERIN ACTIVE INGREDIENT
SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,SUMMIT PHARMACEUTICALS,DIVISION OF CIBA-GEIGY CORPORATION
SYSTEM SIZE: 10 SQUARE CENTIMETER
USUAL DOSE: 0.2 MG RELEASED PER HOUR
Related Searches:
TRANSDERM-NITRO
NITROGLYCERIN TRANSDERMAL SYSTEM
NSN, MFG P/N
6505012122991
NSN
6505-01-212-2991
TRANSDERM-NITRO
NITROGLYCERIN TRANSDERMAL SYSTEM
NSN, MFG P/N
6505012122991
NSN
6505-01-212-2991
MFG
CIBA-GEIGY CORP SUMMIT PHARMACEUTICALS DIV
Description
FEATURES PROVIDED: BANDAGE, ADHESIVE, NONSENSITIZED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: NITROGLYCERIN TRANSDERMAL SYSTEM 25MG 100 SYSTEMS PG
OVERALL STRENGTH IN SYSTEM: 25 MG NITROGLYCERIN ACTIVE INGREDIENT
SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,SUMMIT PHARMACEUTICALS,DIVISION OF CIBA-GEIGY CORPORATION
SYSTEM SIZE: 10 SQUARE CENTIMETER
USUAL DOSE: 0.2 MG RELEASED PER HOUR
Related Searches:
2922
NITROGLYCERIN TRANSDERMAL SYSTEM
NSN, MFG P/N
6505012122992
NSN
6505-01-212-2992
2922
NITROGLYCERIN TRANSDERMAL SYSTEM
NSN, MFG P/N
6505012122992
NSN
6505-01-212-2992
MFG
CIBA-GEIGY CORP SUMMIT PHARMACEUTICALS DIV
Description
FEATURES PROVIDED: BANDAGE, ADHESIVE, NONSENSITIZED
OVERALL STRENGTH IN SYSTEM: 50 MG NITROGLYCERIN ACTIVE INGREDIENT
SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,SUMMIT PHARMACEUTICALS,DIVISION OF CIBA-GEIGY CORPORATION
SYSTEM SIZE: 20 SQUARE CENTIMETER
USUAL DOSE: 0.4 MG RELEASED PER HOUR
